Allspring Global Investments Holdings LLC Sells 1,493 Shares of Privia Health Group, Inc. (NASDAQ:PRVA)

Allspring Global Investments Holdings LLC cut its position in shares of Privia Health Group, Inc. (NASDAQ:PRVA) by 15.3% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 8,265 shares of the company’s stock after selling 1,493 shares during the period. Allspring Global Investments Holdings LLC’s holdings in Privia Health Group were worth $151,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the business. Vanguard Group Inc. grew its position in Privia Health Group by 1.1% during the 1st quarter. Vanguard Group Inc. now owns 11,400,035 shares of the company’s stock worth $223,327,000 after acquiring an additional 121,701 shares during the last quarter. Millennium Management LLC raised its holdings in shares of Privia Health Group by 2,994.2% during the second quarter. Millennium Management LLC now owns 1,138,526 shares of the company’s stock worth $19,788,000 after acquiring an additional 1,101,730 shares during the period. Dimensional Fund Advisors LP grew its holdings in shares of Privia Health Group by 18.4% during the second quarter. Dimensional Fund Advisors LP now owns 1,118,619 shares of the company’s stock worth $19,441,000 after buying an additional 173,934 shares in the last quarter. First Light Asset Management LLC bought a new stake in shares of Privia Health Group in the first quarter worth $21,620,000. Finally, Bellevue Group AG raised its holdings in Privia Health Group by 0.7% during the first quarter. Bellevue Group AG now owns 1,059,171 shares of the company’s stock worth $20,749,000 after acquiring an additional 7,475 shares in the last quarter. 94.48% of the stock is owned by institutional investors.

Privia Health Group Price Performance

Shares of NASDAQ:PRVA opened at $18.99 on Monday. Privia Health Group, Inc. has a one year low of $15.92 and a one year high of $24.35. The company has a market cap of $2.27 billion, a price-to-earnings ratio of 158.25, a PEG ratio of 4.17 and a beta of 0.76. The firm has a fifty day moving average price of $18.42 and a two-hundred day moving average price of $18.27.

Privia Health Group (NASDAQ:PRVA) last issued its earnings results on Thursday, August 8th. The company reported $0.03 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.05 by ($0.02). Privia Health Group had a return on equity of 2.42% and a net margin of 0.88%. The firm had revenue of $422.30 million during the quarter, compared to the consensus estimate of $411.50 million. During the same quarter in the prior year, the business posted $0.06 EPS. The firm’s revenue for the quarter was up 2.2% on a year-over-year basis. Equities research analysts expect that Privia Health Group, Inc. will post 0.17 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently weighed in on the company. Royal Bank of Canada restated an “outperform” rating and issued a $28.00 price target on shares of Privia Health Group in a research note on Wednesday, August 14th. Evercore ISI dropped their price objective on shares of Privia Health Group from $23.00 to $20.00 and set an “outperform” rating for the company in a research note on Tuesday, July 9th. KeyCorp began coverage on shares of Privia Health Group in a report on Friday, October 11th. They set an “overweight” rating and a $23.00 target price on the stock. Finally, Robert W. Baird upped their target price on Privia Health Group from $23.00 to $24.00 and gave the company an “outperform” rating in a report on Monday, August 26th. Two equities research analysts have rated the stock with a hold rating, twelve have assigned a buy rating and two have issued a strong buy rating to the company. According to MarketBeat, the stock has an average rating of “Buy” and a consensus target price of $24.73.

Insider Buying and Selling

In other news, CEO Parth Mehrotra sold 135,142 shares of Privia Health Group stock in a transaction dated Tuesday, September 10th. The stock was sold at an average price of $18.50, for a total value of $2,500,127.00. Following the completion of the transaction, the chief executive officer now owns 247,771 shares of the company’s stock, valued at $4,583,763.50. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 14.20% of the stock is owned by insiders.

Privia Health Group Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.